News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
269,182 Results
Type
Article (14197)
Company Profile (305)
Press Release (254680)
Section
Business (81165)
Career Advice (152)
Deals (13708)
Drug Delivery (34)
Drug Development (50683)
Employer Resources (31)
FDA (5829)
Job Trends (5169)
News (147142)
Policy (10308)
Tag
Academia (909)
Alliances (22426)
Alzheimer's disease (758)
Approvals (5805)
Artificial intelligence (68)
Bankruptcy (97)
Best Places to Work (4554)
Biotechnology (249)
Breast cancer (109)
Cancer (889)
Cardiovascular disease (71)
Career advice (133)
CAR-T (73)
Cell therapy (219)
Clinical research (40446)
Collaboration (314)
Compensation (131)
COVID-19 (1012)
C-suite (78)
Cystic fibrosis (66)
Data (986)
Diabetes (86)
Diagnostics (1294)
Drug discovery (56)
Earnings (29405)
Events (47745)
Executive appointments (249)
FDA (6197)
Funding (310)
Gene editing (63)
Gene therapy (163)
GLP-1 (311)
Government (1073)
Healthcare (6668)
Infectious disease (1049)
Inflammatory bowel disease (98)
IPO (7272)
Job creations (881)
Job search strategy (128)
Layoffs (188)
Legal (1486)
Lung cancer (130)
Lymphoma (62)
Manufacturing (90)
Medical device (2710)
Medtech (2711)
Mergers & acquisitions (6573)
Metabolic disorders (259)
Neuroscience (1001)
NextGen Class of 2024 (2031)
Non-profit (848)
Northern California (1096)
Obesity (141)
Opinion (91)
Parkinson's disease (75)
Patents (61)
People (25477)
Phase I (14232)
Phase II (18800)
Phase III (11912)
Pipeline (369)
Postmarket research (872)
Preclinical (5996)
Radiopharmaceuticals (205)
Rare diseases (202)
Real estate (1500)
Regulatory (8456)
Research institute (943)
Southern California (976)
Startups (1996)
United States (8713)
Vaccines (165)
Weight loss (83)
Date
Last 7 days (368)
Last 30 days (1388)
Last 365 days (20712)
2024 (20624)
2023 (22680)
2022 (27896)
2021 (28771)
2020 (24039)
2019 (16583)
2018 (11992)
2017 (14106)
2016 (12131)
2015 (14803)
2014 (10725)
2013 (7753)
2012 (7878)
2011 (7943)
2010 (7696)
Location
Africa (147)
Asia (17215)
Australia (2924)
California (2482)
Canada (821)
China (203)
Colorado (91)
Connecticut (103)
Europe (39432)
Florida (273)
Georgia (71)
Illinois (156)
Indiana (61)
Maryland (332)
Massachusetts (1961)
Michigan (58)
Minnesota (101)
New Jersey (633)
New York (684)
North Carolina (422)
Northern California (1096)
Ohio (82)
Pennsylvania (497)
South America (214)
Southern California (976)
Texas (279)
Washington State (247)
269,182 Results for "topas therapeutics gmbh".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Business
Topas Therapeutics Appoints Hugo Fry as CEO
Topas Therapeutics, a clinical-stage biotech company developing novel antigen-specific immune tolerance therapies to treat autoimmune disorders, announced the appointment of Hugo Fry as its new Chief Executive Officer.
May 7, 2024
·
3 min read
Press Releases
Topas Therapeutics Announces Positive Topline Results from Phase 2a Trial Evaluating TPM502 in Patients with Celiac Disease
October 15, 2024
·
3 min read
Press Releases
Niterra Ventures Company Invests $18M Additional Funding in Neoplas Med GmbH
November 25, 2024
·
4 min read
Deals
Great Point Partners Acquires Lyocontract GmbH, Germany-Based Drug Product CDMO
Great Point Partners, a Greenwich-based investment firm focused exclusively on the health care industry, announced the acquisition of Lyocontract GmbH, a premium independent drug product contract development and manufacturing organization based in Ilsenburg, Germany.
June 13, 2024
·
3 min read
Business
Oakwood Chemical Announces Strategic Partnership with EMP Biotech GmbH
Oakwood Chemical is thrilled to unveil its collaboration with EMP Biotech GmbH, a move set to streamline the oligo synthesis supply chain.
April 9, 2024
·
2 min read
Press Releases
FGK Clinical Research GmbH Highlights 3.5 Years of Success with Flex Databases
October 10, 2024
·
1 min read
Drug Development
Topas Therapeutics Initiates Phase 2a Clinical Trial for TPM502 in Celiac Disease; Appoints Chief Business Officer and Chief Operating Officer
Topas Therapeutics announced the launch of a Phase 2a clinical study evaluating the safety, tolerability and pharmacodynamics of TPM502 in patients with celiac disease.
May 25, 2023
·
5 min read
Drug Development
HD Immune GmbH Foundation and Publication of Latest Pre-Clinical Data
HD Immune GmbH announces commencement of operations by its two founders Dr. Stefan Bartl and Dr. Lionel Wightman.
January 23, 2024
·
2 min read
Defence Therapeutics Signs with German Based FMS Consult GmbH for Financing Strategy to Support Defence Pipeline Growth
Vancouver, British Columbia--(Newsfile Corp. - April 17, 2024) - Defence Therapeutics Inc. (CSE: DTC) (OTCQB: DTCFF) (FSE: DTC) (“Defence” or the “Company”), a Canadian biopharmaceutical company developing novel immune-oncology therapeutics and drug delivery technologies, is pleased to announce that...
April 17, 2024
·
3 min read
Biocure Technology Inc. Enters into Exclusive Letter Agreement to Acquire Atriva Therapeutics GmbH in Reverse Takeover Transaction
Biocure Technology Inc. (CSE: CURE) (“CURE” or the “Company”) announces that it has entered into an exclusive letter agreement dated September 8, 2023 with Atriva Therapeutics GmbH.
September 19, 2023
·
8 min read
1 of 26,919
Next
